Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805268651> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2805268651 endingPage "012009" @default.
- W2805268651 startingPage "012009" @default.
- W2805268651 abstract "Colon cancer is a cancer with characteristics of cyclooxygenase (COX-2) protein overexpression. Increased COX-2 expression may inhibit regulation of apoptotic mechanism. Andrographolide was known has activity as an anticancer. The aimed of this study was determined the mechanism and affinity of andrographolide with COX-2 protein as anti-colon cancer using molecular docking. In silico assay used molecular docking method with Chimera 1.10.1 (use for protein preparation COX-2), Hyperchem 8 (use for optimization 3D structure of andrographolide), and Autodock 4.2 programs (use for molecular docking).The results in molecular docking was a binding energy value of and hydrogen bonds. Data were compared with native ligand, celecoxib, and meloxicam. The binding energy values between COX-2 protein with andrographolide, native ligand, celecoxib, and meloxicam were respectively -8.66; -9.94; -10.12; and -7.68 kcal/mol. This indicate that andrographolide had a stronger affinity and more stable than meloxicam for COX-2 protein with hydrogen bonds on Arg120 amino acid. Based on the results obtained, andrographolide had an anti-colon cancer activity caused it can bind to the protein COX-2. The mechanism of andrographolide as anti-colon cancer by inhibited the overexpression of COX-2 in order to increase apoptotic regulation." @default.
- W2805268651 created "2018-06-13" @default.
- W2805268651 creator A5004681421 @default.
- W2805268651 creator A5018057366 @default.
- W2805268651 creator A5024003778 @default.
- W2805268651 creator A5038012423 @default.
- W2805268651 creator A5085613846 @default.
- W2805268651 creator A5086205656 @default.
- W2805268651 date "2018-06-04" @default.
- W2805268651 modified "2023-10-14" @default.
- W2805268651 title "Cytotoxic activity of andrographolide in colon cancer through inhibition cox-2 by in silico study" @default.
- W2805268651 cites W1967020486 @default.
- W2805268651 cites W2020430786 @default.
- W2805268651 cites W2085852125 @default.
- W2805268651 cites W2153198430 @default.
- W2805268651 doi "https://doi.org/10.1088/1742-6596/1040/1/012009" @default.
- W2805268651 hasPublicationYear "2018" @default.
- W2805268651 type Work @default.
- W2805268651 sameAs 2805268651 @default.
- W2805268651 citedByCount "1" @default.
- W2805268651 countsByYear W28052686512020 @default.
- W2805268651 crossrefType "journal-article" @default.
- W2805268651 hasAuthorship W2805268651A5004681421 @default.
- W2805268651 hasAuthorship W2805268651A5018057366 @default.
- W2805268651 hasAuthorship W2805268651A5024003778 @default.
- W2805268651 hasAuthorship W2805268651A5038012423 @default.
- W2805268651 hasAuthorship W2805268651A5085613846 @default.
- W2805268651 hasAuthorship W2805268651A5086205656 @default.
- W2805268651 hasBestOaLocation W28052686511 @default.
- W2805268651 hasConcept C104317684 @default.
- W2805268651 hasConcept C121608353 @default.
- W2805268651 hasConcept C126322002 @default.
- W2805268651 hasConcept C159110408 @default.
- W2805268651 hasConcept C185592680 @default.
- W2805268651 hasConcept C2775905019 @default.
- W2805268651 hasConcept C2776467144 @default.
- W2805268651 hasConcept C2779751750 @default.
- W2805268651 hasConcept C2780152424 @default.
- W2805268651 hasConcept C2781357234 @default.
- W2805268651 hasConcept C41685203 @default.
- W2805268651 hasConcept C502942594 @default.
- W2805268651 hasConcept C526805850 @default.
- W2805268651 hasConcept C55493867 @default.
- W2805268651 hasConcept C71924100 @default.
- W2805268651 hasConcept C86803240 @default.
- W2805268651 hasConcept C98274493 @default.
- W2805268651 hasConceptScore W2805268651C104317684 @default.
- W2805268651 hasConceptScore W2805268651C121608353 @default.
- W2805268651 hasConceptScore W2805268651C126322002 @default.
- W2805268651 hasConceptScore W2805268651C159110408 @default.
- W2805268651 hasConceptScore W2805268651C185592680 @default.
- W2805268651 hasConceptScore W2805268651C2775905019 @default.
- W2805268651 hasConceptScore W2805268651C2776467144 @default.
- W2805268651 hasConceptScore W2805268651C2779751750 @default.
- W2805268651 hasConceptScore W2805268651C2780152424 @default.
- W2805268651 hasConceptScore W2805268651C2781357234 @default.
- W2805268651 hasConceptScore W2805268651C41685203 @default.
- W2805268651 hasConceptScore W2805268651C502942594 @default.
- W2805268651 hasConceptScore W2805268651C526805850 @default.
- W2805268651 hasConceptScore W2805268651C55493867 @default.
- W2805268651 hasConceptScore W2805268651C71924100 @default.
- W2805268651 hasConceptScore W2805268651C86803240 @default.
- W2805268651 hasConceptScore W2805268651C98274493 @default.
- W2805268651 hasLocation W28052686511 @default.
- W2805268651 hasOpenAccess W2805268651 @default.
- W2805268651 hasPrimaryLocation W28052686511 @default.
- W2805268651 hasRelatedWork W1523599547 @default.
- W2805268651 hasRelatedWork W1994492193 @default.
- W2805268651 hasRelatedWork W2062202134 @default.
- W2805268651 hasRelatedWork W2100517305 @default.
- W2805268651 hasRelatedWork W2754402576 @default.
- W2805268651 hasRelatedWork W2779829070 @default.
- W2805268651 hasRelatedWork W3093357441 @default.
- W2805268651 hasRelatedWork W3121073616 @default.
- W2805268651 hasRelatedWork W3139295529 @default.
- W2805268651 hasRelatedWork W4205374063 @default.
- W2805268651 hasVolume "1040" @default.
- W2805268651 isParatext "false" @default.
- W2805268651 isRetracted "false" @default.
- W2805268651 magId "2805268651" @default.
- W2805268651 workType "article" @default.